| MIR183 |
|
microRNA 183
|
|
|
0.494 |
0.885 |
| MIR96 |
|
microRNA 96
|
|
|
0.536 |
0.769 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| RSS |
|
Russell Silver syndrome
|
|
|
0.578 |
0.692 |
| MIR495 |
|
microRNA 495
|
|
|
0.573 |
0.654 |
| GHS |
|
Goldenhar syndrome
|
|
|
0.659 |
0.615 |
| PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
| GBA3 |
Q9H227
|
glucosylceramidase beta 3 (gene/pseudogene)
|
Enzyme
|
|
0.705 |
0.538 |
| BAS |
|
Beta-adrenergic stimulation, response to
|
|
|
0.711 |
0.346 |
| DURS1 |
|
Duane retraction syndrome 1
|
|
|
0.839 |
0.154 |
| DNAH8 |
Q96JB1
|
dynein axonemal heavy chain 8
|
Enzyme
|
1.1E-60 |
0.556 |
0.731 |
| ATP2C2 |
O75185
|
ATPase secretory pathway Ca2+ transporting 2
|
Transporter
|
5.0E-60 |
0.769 |
0.308 |
| CFTR |
P13569
|
CF transmembrane conductance regulator
|
Ion channel
|
2.2E-58 |
0.424 |
0.885 |
| SYNE1 |
Q8NF91
|
spectrin repeat containing nuclear envelope protein 1
|
|
3.2E-52 |
0.511 |
0.846 |
| PATJ |
Q8NI35
|
PATJ crumbs cell polarity complex component
|
|
1.2E-50 |
0.751 |
0.538 |
| MYO5C |
Q9NQX4
|
myosin VC
|
Cellular structure
|
7.8E-37 |
0.805 |
0.231 |
| CHD1L |
Q86WJ1
|
chromodomain helicase DNA binding protein 1 like
|
|
1.0E-36 |
0.631 |
0.577 |
| PLA2R1 |
Q13018
|
phospholipase A2 receptor 1
|
|
3.2E-30 |
0.633 |
0.577 |
| TTC21B |
Q7Z4L5
|
tetratricopeptide repeat domain 21B
|
|
2.7E-26 |
0.619 |
0.654 |
| CYP2D6 |
P10635
|
cytochrome P450 family 2 subfamily D member 6
|
|
1.1E-25 |
0.437 |
0.885 |
| PCDH15 |
Q96QU1
|
protocadherin related 15
|
|
8.0E-25 |
0.601 |
0.577 |
| INSRR |
P14616
|
insulin receptor related receptor
|
Kinase
|
5.4E-24 |
0.508 |
0.808 |
| HAL |
P42357
|
histidine ammonia-lyase
|
|
2.5E-23 |
0.641 |
0.538 |
| FAM184A |
Q8NB25
|
family with sequence similarity 184 member A
|
|
1.1E-21 |
0.821 |
0.115 |
| APPL2 |
Q8NEU8
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
|
|
1.2E-18 |
0.700 |
0.423 |